A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast canc ...
Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system's ability to fight cancer, potentially paving the way for new treatments.
The Prognostic Lung Fibrosis Consortium (PROLIFIC), a collaborative consortium advancing biomarker tools for pulmonary fibrosis (PF) research, announced today that the PROLIFIC Risk Score has been ...
Oncotelic Therapeutics Inc. 's (OTCQB: OTLC) Sapu Nano joint venture is making progress with Sapu003, its intravenous Deciparticle formulation of everolimus, the powerful drug to fight cancer and ...
Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...
Cancer has long been treated as a mass of rogue cells, but the real power lies in the intricate communication networks ...
Quanterix Corporation , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced publication of a landmark study in the prestigious ...
Each ‘WePurpler’ will use their wisdom, imagination, and creativity to plot a ‘Purple Path’ that is personal to them and features the respective iconic ‘purple’ locations in each of the company's ...
Important FDA-approved drugs to treat HIV and cancer can save lives, but they come with their own risks. Some drugs used clinically are known to cause neurological side effects in up to half of ...
Company engages Standards Council of Canada; targets ISO 15189 accreditation for early 2026 Vancouver, British Columbia–(Newsfile Corp. – December 23, 2025) – BioMark Diagnostics Inc. (CSE: BUX) ...
Coherus Oncology, Inc. is rated a Buy driven by a promising clinical pipeline and undervaluation. Learn more about CHRS stock ...